Effect of Centrally Injected Allopregnanolone on Sexual Receptivity, Luteinizing Hormone Release, Hypothalamic Dopamine Turnover, and Release in Female Rats

Overview

Journal Endocrine

Specialty Endocrinology

Date 2002 Jun 4

PMID 12041918

Citations 6

Authors

Myriam R Laconi

Ricardo J Cabrera

Affiliations

Soon will be listed here.

Abstract

The effect of intracerebroventricular (icv) injection of allopregnanolone (5alpha-pregnan-3alpha-ol-20-one) on the dopaminergic and reproductive function in ovariectomized rats primed with estrogen and progesterone was investigated. Thirty minutes after icv allopregnanolone injection, the sexual receptivity, luteinizing hormone (LH) release, dopamine content, and release in the medial basal hypothalamus (MBH) and preoptic area (POA) were determined. After allopregnanolone injection, LH serum levels were reduced (p < 0.001) and lordosis behavior was inhibited (p < 0.005). Intracerebroventricular injection of bicuculline (a gamma-aminobutyric acidA [GABAA] antagonist) alone was ineffective. The injection of allopregnanolone plus bicuculline blocked the effects of allopregnanolone on sexual receptivity and on LH serum levels. At the same time, endogenous dopamine concentration in both the MBH and POA was augmented (p < 0.005 and p < 0.006, respectively) and the turnover rate decreased in both structures. Moreover, in vitro 3H-dopamine release from MBH and POA was lower in rats injected with allopregnanolone in comparison with vehicle-treated rats. These results suggest that allopregnanolone influences the dopaminergic mechanisms in female rats, which may, in turn, be responsible for the reduced reproductive activity. Allopregnanolone may exert its effects on sexual behavior through GABAA receptor modulation and a decrease in dopaminergic activity in the MBH and POA. These actions could explain the inhibition of LH release.

Citing Articles

Local effect of allopregnanolone in rat ovarian steroidogenesis, follicular and corpora lutea development.

Caceres A, Cardone D, Sanhueza M, Bosch I, Cuello-Carrion F, Rodriguez G Sci Rep. 2024; 14(1):6402.

PMID: 38493224 PMC: 10944484. DOI: 10.1038/s41598-024-57102-1.

Dynorphin and GABAA Receptor Signaling Contribute to Progesterone's Inhibition of the LH Surge in Female Mice.

Liu Y, Li X, Ivanova D, Lass G, He W, Chen Q Endocrinology. 2020; 161(5).

PMID: 32181477 PMC: 7153819. DOI: 10.1210/endocr/bqaa036.

Allopregnanolone alters follicular and luteal dynamics during the estrous cycle.

Asensio J, Caceres A, Pelegrina L, Sanhueza M, Scotti L, Parborell F Reprod Biol Endocrinol. 2018; 16(1):35.

PMID: 29636114 PMC: 5894215. DOI: 10.1186/s12958-018-0353-y.

Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications.

Cai H, Cao T, Zhou X, Yao J Front Psychiatry. 2018; 9:73.

PMID: 29568275 PMC: 5852066. DOI: 10.3389/fpsyt.2018.00073.

The Neurosteroid Progesterone Underlies Estrogen Positive Feedback of the LH Surge.

Micevych P, Sinchak K Front Endocrinol (Lausanne). 2012; 2:90.

PMID: 22654832 PMC: 3356049. DOI: 10.3389/fendo.2011.00090.

References

Fuchs E, Mansky T, Stock K, Vijayan E, Wuttke W . Involvement of catecholamines and glutamate in GABAergic mechanism regulatory to luteinizing hormone and prolactin secretion. Neuroendocrinology. 1984; 38(6):484-9. DOI: 10.1159/000123937. View

de Greef W, Merkx J . Receptivity, proceptivity and attractivity of pregnant and pseudopregnant rats. Behav Brain Res. 1982; 4(2):203-8. DOI: 10.1016/0166-4328(82)90073-0. View

Gallo R . Neuroendocrine regulation of pulsatile luteinizing hormone release in the rat. Neuroendocrinology. 1980; 30(2):122-31. DOI: 10.1159/000122986. View

Adler B, Crowley W . Evidence for gamma-aminobutyric acid modulation of ovarian hormonal effects on luteinizing hormone secretion and hypothalamic catecholamine activity in the female rat. Endocrinology. 1986; 118(1):91-7. DOI: 10.1210/endo-118-1-91. View

Crowley W . Sex differences in the responses of hypothalamic luteinizing hormone-releasing hormone and catecholamine systems to ovarian hormones and naloxone: implications for sexual differentiation of luteinizing hormone secretion in rats. Brain Res. 1988; 461(2):314-21. DOI: 10.1016/0006-8993(88)90261-2. View

Cabrera R, Bregonzio C . Turnover rate and stimulus-evoked release of dopamine by progesterone and N-methyl-D-aspartic acid in rat striatum during pregnancy. Eur J Pharmacol. 1996; 317(1):55-9. DOI: 10.1016/s0014-2999(96)00704-2. View

DONOSO A, Seltzer A, Navarro C, Cabrera R, Lopez F, Negro-Vilar A . Regulation of luteinizing hormone-releasing hormone and luteinizing hormone secretion by hypothalamic amino acids. Braz J Med Biol Res. 1994; 27(4):921-32. View

Calogero A, Palumbo M, Bosboom A, Burrello N, Ferrara E, Palumbo G . The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the gamma-aminobutyric acidA receptor. J Endocrinol. 1998; 158(1):121-5. DOI: 10.1677/joe.0.1580121. View

Rotsztejn W, Charli J, Pattou E, Epelbaum J, Kordon C . In vitro release of luteinizing hormone-releasing hormone (LHRH) from rat mediobasal hypothalamus: effects of potassium, calcium and dopamine. Endocrinology. 1976; 99(6):1663-6. DOI: 10.1210/endo-99-6-1663. View

10.

Akwa Y, Baulieu E . [Neurosteroids: behavioral aspects and physiological implications]. J Soc Biol. 1999; 193(3):293-8. View

11.

Havern R, Whisnant C, Goodman R . Hypothalamic sites of catecholamine inhibition of luteinizing hormone in the anestrous ewe. Biol Reprod. 1991; 44(3):476-82. DOI: 10.1095/biolreprod44.3.476. View

12.

Dudley S, Ramirez I, Wade G . Estrous behavior and pituitary and brain cell nuclear retention of [3H]estradiol in chronically insulin-deficient female rats. Neuroendocrinology. 1981; 33(1):7-11. DOI: 10.1159/000123193. View

13.

Schneider H, McCANN S . Possible role of dopamine as transmitter to promote discharge of LH-releasing factor. Endocrinology. 1969; 85(1):121-32. DOI: 10.1210/endo-85-1-121. View

14.

Barbaccia M, Roscetti G, Bolacchi F, Concas A, Mostallino M, Purdy R . Stress-induced increase in brain neuroactive steroids: antagonism by abecarnil. Pharmacol Biochem Behav. 1996; 54(1):205-10. DOI: 10.1016/0091-3057(95)02133-7. View

15.

Halasz B . Neuroendocrinology in 1992. Neuroendocrinology. 1993; 57(6):1196-207. DOI: 10.1159/000126486. View

16.

Lofstrom A, Agnati L, Fuxe K, Hokfelt T . Evidence for an inhibitory dopaminergic and stimulatory noradrenergic hypothalamic influence on PMS-induced ovulation in the immature rat. II. A pharmacological analysis. Neuroendocrinology. 1977; 24(5-6):289-316. DOI: 10.1159/000122717. View

17.

Frye C, DeBold J . 3 alpha-OH-DHP and 5 alpha-THDOC implants to the ventral tegmental area facilitate sexual receptivity in hamsters after progesterone priming to the ventral medial hypothalamus. Brain Res. 1993; 612(1-2):130-7. DOI: 10.1016/0006-8993(93)91653-a. View

18.

Melis M, Argiolas A . Dopamine and sexual behavior. Neurosci Biobehav Rev. 1995; 19(1):19-38. DOI: 10.1016/0149-7634(94)00020-2. View

19.

Wilson C, Thody A, Hole D, Grierson J, Celis M . Interaction of estradiol, alpha-melanocyte-stimulating hormone, and dopamine in the regulation of sexual receptivity in the female rat. Neuroendocrinology. 1991; 54(1):14-22. DOI: 10.1159/000125845. View

20.

Herbison A, Robinson J, Skinner D . Distribution of estrogen receptor-immunoreactive cells in the preoptic area of the ewe: co-localization with glutamic acid decarboxylase but not luteinizing hormone-releasing hormone. Neuroendocrinology. 1993; 57(4):751-9. DOI: 10.1159/000126433. View